Rationale, design and statistical analysis of a prospective randomized trial comparing initially intensified vs standard dose regimens of enteric-coated mycophenolate sodium in De novo renal transplant patients

被引:0
|
作者
Budde, Klemens [1 ]
Arns, Wolfgang [2 ]
Grandaliano, Giuseppe [3 ]
Kiberd, Bryce [4 ]
Kuypers, Dirk [5 ]
Walker, Rowan [6 ]
机构
[1] Univ Hosp, Charite, Dept Nephrol, Berlin, Germany
[2] Merheim Med Ctr, Transplant Ctr, Cologne, Germany
[3] Univ Bari, Policlin, Bari, Italy
[4] Dalhousie Univ, Dept Med, Halifax, NS, Canada
[5] Univ Hosp Louvain, Dept Nephrol & Renal Transplantat, Louvain, Belgium
[6] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:208 / 208
页数:1
相关论文
共 50 条
  • [31] Intensified Dosing of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant Recipients Results in Early High Drug Exposure and Lower Rates of Acute Rejection Versus Standard Dosing.
    Budde, K.
    Tedesco Silva, H.
    Arns, W.
    Kuypers, D.
    Shoker, A.
    Prestele, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 46 - 46
  • [32] Efficacy and safety of enteric-coated mycophenolate sodium, cyclosporine and steroids in De novo pediatric renal transplant patients:: 6-month results
    Niaudet, Patrick
    Loirat, Chantal
    Foulard, Michel
    Tsimaratos, Michel
    Lemay, Djamila
    TRANSPLANT INTERNATIONAL, 2007, 20 : 313 - 313
  • [33] 12 MONTH FOLLOW UP RESULTS OF AN INITIAL INTENSIFIED DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Arns, W.
    Kuypers, D.
    Tedesco Silva, H.
    Budde, K.
    Shoker, A.
    Prestele, H.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 81 - 82
  • [34] Improved Rejection Prophylaxis from an Initial Intensified Dosing Regimen of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients.
    Budde, K.
    Tedesco-Silva, H.
    Arns, W.
    Zeier, M.
    Shoker, A.
    del Castillo, D.
    Grandaliano, G.
    Kiberd, B.
    Walker, R.
    Kawakami, F. T.
    Kuypers, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 393 - 393
  • [35] Enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients: Pharmacokinetic (PK) results.
    Sechaud, R
    Yeh, CM
    Balez, S
    Koelle, E
    Hummel, M
    Gerosa, G
    Yonan, N
    Ross, H
    Miller, LW
    Brambilla, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 250 - 250
  • [36] Renal function with enteric-coated mycophenolate sodium in combination with reduced and standard tacrolimus levels: Results of a 6-month comparative study in de novo renal transplant recipients
    Hart, Marquis
    Chan, Laurence
    Andres, Amado
    Bloom, Roy
    Bunnapradist, Suphamai
    Kaplan, Bruce
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 583 - 583
  • [37] RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM TREATED DE NOVO RENAL TRANSPLANT RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: THE ZEUS STUDY
    Becker, T.
    Arns, W.
    Budde, K.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Reinke, P.
    Sommerer, C.
    Pietruck, F.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 78 - 79
  • [38] Analysis of Renal Function in Everolimus/Enteric-Coated Mycophenolate Sodium Treated De Novo Renal Transplant Recipients after Calcineurin Inhibitor Withdrawal: The ZEUS Study.
    Budde, K.
    Becker, T.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 259 - 259
  • [39] Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: Results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine
    Nashan, B.
    Suwelack, B.
    Ivens, K.
    Arns, W.
    Lhotta, K.
    Bourbigot, B.
    Budde, K.
    Fischer, W.
    Pietruck, F.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (09) : 2856 - 2859
  • [40] Enteric-coated mycophenolate sodium (EC-MPS) vs mycophenolate mofetil (MMF) in de novo heart transplant patients: 6-month efficacy and safety results.
    Kobashigawa, JA
    Davis, SF
    Renlund, DG
    Eisen, H
    Miller, L
    Lehmkuhl, H
    Gambino, A
    Brambilla, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 281 - 281